Evidence – Human-Relevant Safety NAMs for Translational Confidence & Therapeutic Index in Oncology Drug Development

Name: Evidence – Human-Relevant Safety NAMs for Translational Confidence & Therapeutic Index in Oncology Drug Development
Start: 2026-12-03T10:40
Location: Hilton London Canary Wharf

Tumour Models London Summit 2026 · 3 December 2026 · 10:40

Evidence – Human-Relevant Safety NAMs for Translational Confidence & Therapeutic Index in Oncology Drug Development was a session at Tumour Models London Summit 2026 on 3 December 2026 in London, with 1 speaker on record.

Speakers

Sonja Gill — Speaker Director, Oncology Safety Combinations, Clinical Pharmacology & Safety Sciences, AstraZeneca